FASN and cancer: We and other groups also found that either the imbalanced circulating cholesterol or upregulated expression of FASN, ACACA and SREBPs correlated with a poorer diagnosis in different cancers, implying a significance of the lipid metabolism during the cancer development in clinic [100,101,102].